Literature DB >> 6613752

Serum biochemistry in relation to the action of azathioprine in rheumatoid arthritis.

J S Dixon, H A Bird, N G Sitton, M E Pickup, P A Leatham, V Wright.   

Abstract

In a long-term study we have been comparing biochemical changes in the blood of patients with classical or definite rheumatoid arthritis (RA) when groups of patients are treated for the first time with specific anti-rheumatoid drugs for a six-month period. One such group was treated for 26 weeks with azathioprine. Biochemical and clinical assessments were made at each of 10 clinic visits during the treatment period. Side-effects prevented six patients completing the study. Clinical improvement in the remaining patients was accompanied by a reduction in acute phase proteins, increases in total serum sulphydryl and serum histidine, but little or no change in immunological variables. Comparison of correlation matrices constructed between clinical and laboratory variables for azathioprine and drugs previously tested suggests that azathioprine is more effective than a control group on aspirin alone and in some ways comparable with D-penicillamine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6613752     DOI: 10.1007/bf01971492

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  24 in total

1.  Clinical aspects: specificity and mode of action of immunosuppressives.

Authors:  H L Currey
Journal:  Rheumatol Rehabil       Date:  1976-08

2.  SERUM SULFHYDRYL DETERMINATIONS AND SIGNIFICANCE IN CONNECTIVE TISSUE DISEASES.

Authors:  A LORBER; C M PEARSON; W L MEREDITH; L E GANTZ-MANDELL
Journal:  Ann Intern Med       Date:  1964-09       Impact factor: 25.391

3.  Toxicity of immunosuppressive drugs in man.

Authors:  J L Decker
Journal:  Arthritis Rheum       Date:  1973 Jan-Feb

4.  On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum.

Authors:  M E Pickup; J S Dixon; H A Bird
Journal:  J Pharm Pharmacol       Date:  1980-04       Impact factor: 3.765

5.  A comparison of the erythrocyte sedimentation rate and plasma viscosity in detecting changes in plasma proteins.

Authors:  R M Hutchinson; R D Eastham
Journal:  J Clin Pathol       Date:  1977-04       Impact factor: 3.411

6.  Plasma viscosity--a new appraisal of its use as an index of disease activity in rheumatoid arthritis.

Authors:  M E Pickup; J S Dixon; C Hallett; H A Bird; V Wright
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

7.  A comparison of serum biochemistry in ankylosing spondylitis, seronegative and seropositive rheumatoid arthritis.

Authors:  J S Dixon; H A Bird; V Wright
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

8.  Inhibition of denaturation of human gamma globulin by a mixture of L-histidine, L-cystine, and copper, and its clinical implication in rheumatoid arthritis.

Authors:  D A Gerber
Journal:  Arthritis Rheum       Date:  1976 May-Jun

9.  A biochemical comparison of alclofenac and D-penicillamine in rheumatoid arthritis.

Authors:  H A Bird; J S Dixon; M E Pickup; M R Lee; V Wright
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

10.  Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.

Authors:  H L Currey; J Harris; R M Mason; J Woodland; T Beveridge; C J Roberts; D W Vere; A S Dixon; J Davies; B Owen-Smith
Journal:  Br Med J       Date:  1974-09-28
View more
  2 in total

Review 1.  Treatment of severe rheumatoid arthritis.

Authors:  V Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-15

Review 2.  Disease-modifying antirheumatic drugs. Potential effects in older patients.

Authors:  G Gardner; D E Furst
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.